FFBW, Inc. (FFBW)
OTCMKTS · Delayed Price · Currency is USD
13.75
0.00 (0.00%)
Jul 31, 2025, 11:23 AM EDT
Ligand Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 12.19 | 6.13 | 5.75 | 10.89 | 67 | 41.48 | Upgrade |
Investment Securities | 34.58 | 18.67 | 22.52 | 25.98 | 23.7 | 27.84 | Upgrade |
Mortgage-Backed Securities | - | 18.09 | 20.34 | 22.87 | 26.06 | 37.68 | Upgrade |
Total Investments | 34.58 | 36.76 | 42.86 | 48.85 | 49.75 | 65.52 | Upgrade |
Gross Loans | - | 227.63 | 252.31 | 245.13 | 224.83 | 217.96 | Upgrade |
Allowance for Loan Losses | - | -2.74 | -3.18 | -2.63 | -2.43 | -2.81 | Upgrade |
Other Adjustments to Gross Loans | - | -0.4 | -0.45 | -0.48 | -0.29 | -0.42 | Upgrade |
Net Loans | - | 224.49 | 248.69 | 242.02 | 222.1 | 214.72 | Upgrade |
Property, Plant & Equipment | 6.05 | 6.15 | 7.05 | 7.53 | 5.51 | 5.59 | Upgrade |
Loans Held for Sale | 225.91 | - | - | - | 0.5 | 1.71 | Upgrade |
Accrued Interest Receivable | - | 0.87 | 1.04 | 0.93 | 0.81 | 1 | Upgrade |
Other Real Estate Owned & Foreclosed | - | - | - | - | - | 0.13 | Upgrade |
Other Long-Term Assets | 16.04 | 13.51 | 12.64 | 12.83 | 11.4 | 8.83 | Upgrade |
Total Assets | 294.84 | 287.92 | 318.04 | 323.04 | 357.08 | 338.97 | Upgrade |
Interest Bearing Deposits | 219.04 | 132.64 | 153.93 | 165.25 | 190.16 | 165.21 | Upgrade |
Institutional Deposits | - | 31.07 | 38.67 | 18.12 | 10.85 | 9.49 | Upgrade |
Non-Interest Bearing Deposits | - | 44.95 | 48.84 | 51.29 | 54.24 | 51.8 | Upgrade |
Total Deposits | 219.04 | 208.66 | 241.44 | 234.66 | 255.25 | 226.5 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 8 | 6.5 | - | Upgrade |
Current Portion of Leases | - | - | 0.19 | - | - | - | Upgrade |
Accrued Interest Payable | - | 0.28 | 0.2 | 0.02 | 0.01 | 0.02 | Upgrade |
Federal Home Loan Bank Debt, Long-Term | - | - | - | - | - | 7.5 | Upgrade |
Long-Term Leases | - | - | 0.5 | 0.87 | - | - | Upgrade |
Other Long-Term Liabilities | 2.69 | 3.19 | 1.46 | 1.39 | 1.35 | 1.69 | Upgrade |
Total Liabilities | 221.73 | 212.13 | 243.79 | 244.94 | 263.11 | 235.71 | Upgrade |
Common Stock | 73.11 | 0.05 | 0.05 | 0.06 | 0.07 | 0.08 | Upgrade |
Additional Paid-In Capital | - | 36.35 | 37.82 | 43.63 | 58.27 | 69.09 | Upgrade |
Retained Earnings | - | 46.18 | 43.79 | 42.71 | 40.37 | 38.38 | Upgrade |
Comprehensive Income & Other | - | -6.78 | -7.41 | -8.29 | -4.73 | -4.28 | Upgrade |
Shareholders' Equity | 73.11 | 75.79 | 74.25 | 78.1 | 93.97 | 103.27 | Upgrade |
Total Liabilities & Equity | 294.84 | 287.92 | 318.04 | 323.04 | 357.08 | 338.97 | Upgrade |
Total Debt | - | - | 0.69 | 8.87 | 6.5 | 7.5 | Upgrade |
Net Cash (Debt) | 12.19 | 6.38 | 5.31 | 2.5 | 61.27 | 41.92 | Upgrade |
Net Cash Growth | - | 20.12% | 112.07% | -95.91% | 46.18% | 45.07% | Upgrade |
Net Cash Per Share | 2.72 | 1.43 | 1.14 | 0.46 | 9.50 | 5.97 | Upgrade |
Filing Date Shares Outstanding | 4.13 | 4.41 | 4.5 | 5 | 5.7 | 6.71 | Upgrade |
Total Common Shares Outstanding | 4.13 | 4.41 | 4.5 | 5 | 6.18 | 7.11 | Upgrade |
Book Value Per Share | 17.70 | 17.19 | 16.49 | 15.63 | 15.19 | 14.52 | Upgrade |
Tangible Book Value | 73.04 | 75.79 | 74.25 | 78.1 | 93.97 | 103.27 | Upgrade |
Tangible Book Value Per Share | 17.68 | 17.19 | 16.49 | 15.63 | 15.19 | 14.52 | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.